Interpharm 

$0.000010
2
+$0.00+0%Thursday 20:00

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0041
52W Low
0.00001
Volume
10,000
Avg. Volume
7
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a major player in the pharmaceutical industry, directly competing with Interpharm in various therapeutic areas.
Merck
MRK
Mkt Cap356.01B
Merck operates in similar sectors as Interpharm, producing prescription medicines and vaccines.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson offers a broad range of pharmaceutical products, competing across multiple segments with Interpharm.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie competes in the pharmaceutical sector, particularly in areas like immunology and oncology, overlapping with Interpharm's market.
Lilly(Eli) &
LLY
Mkt Cap1.02T
Eli Lilly is a key competitor in the pharmaceutical industry, with significant overlap in drug development and disease focus areas.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol-Myers Squibb competes with Interpharm in the development and marketing of prescription pharmaceuticals in several therapeutic areas.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline competes globally in the pharmaceutical market, offering products that directly compete with those of Interpharm.
Novartis
NVS
Mkt Cap268B
Novartis is a global healthcare company that produces drugs in direct competition with Interpharm's product lines.
Sanofi
SNY
Mkt Cap95.65B
Sanofi operates globally in the pharmaceutical sector, directly competing with Interpharm in multiple therapeutic areas.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca is involved in the discovery, development, and commercialization of prescription medicines, many of which compete with Interpharm's offerings.

About

Interpharm Holdings, Inc. specializes in the formulation, manufacturing, and commercialization of generic pharmaceuticals, encompassing both prescription-strength and over-the-counter varieties. The company's medicinal products are supplied to a wide array of clients, including significant retail chains, wholesale distributors, managed healthcare organizations, and nationwide distribution networks. Established in 1984, the firm maintains its principal operations in Hauppauge, New York.
Show More
CEO
Raj Sutaria
Employees
670
Country
United States
ISIN
US4605881063

Listings

0 Comments

Share your thoughts

FAQs

What is Interpharm stock price today?▼
The current price of IPAH is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Interpharm stock price performance more closely on the chart.
What is Interpharm stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Interpharm stocks are traded under the ticker IPAH.
Is Interpharm stock price growing?▼
IPAH stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Interpharm has showed a -99.76% decrease.
How many employees does Interpharm have?▼
As of November 1, 2026, the company has 670 employees.
In which sector is Interpharm located?▼
Interpharm operates in the Health & Wellness sector.
When did Interpharm complete a stock split?▼
Interpharm has not had any recent stock splits.
Where is Interpharm headquartered?▼
Interpharm is headquartered in Hauppauge, United States.